Fathom Holdings Inc. current report, 30 July 2020

Filing Summary

Business Context and Reporting Period

Fathom Holdings Inc. filed this Form 8-K on August 4, 2020, reporting events occurring on July 30, 2020 and the closing of its initial public offering on August 4, 2020. The company is listed on the Nasdaq Capital Market under the symbol FTHM.

Offering and Key Financial Metrics

  • The company entered into an underwriting agreement for an offering of 3,430,000 shares of common stock at $10.00 per share.
  • The underwriter received an option to purchase up to 327,000 additional shares from the company and up to 187,500 shares from the selling shareholder within 45 days.
  • At closing, the company issued 3,430,000 shares and received approximately $31.75 million in net proceeds after underwriting discounts and commissions.
  • The company issued the underwriter a warrant to purchase up to 240,100 shares at $11.00 per share. The warrant is exercisable from January 26, 2021 through July 30, 2025.
  • The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics for an operating period.

Material Changes Versus the Prior Comparable Period

  • The filing does not present comparative operating results. The principal reported changes are the completion of the IPO, the related increase in common shares outstanding and cash proceeds, and the issuance of the underwriter warrant.
  • Effective July 27, 2020, the company implemented a 4.71352-for-1 reverse stock split. Shares reserved under the 2017 Stock Plan and 2019 Omnibus Stock Incentive Plan were adjusted accordingly.

Guidance, Outlook, Risks, and Unusual Items

  • No financial guidance or operating outlook is provided.
  • The company, its officers, and directors agreed, subject to specified exceptions, to a 180-day lock-up period after July 30, 2020.
  • The underwriting agreement includes customary representations, closing conditions, indemnification obligations, and termination provisions.
  • The offering and reverse stock split may affect share count, per-share metrics, dilution, and trading comparability.
  • The filing states that the underwriting agreement is not intended to provide additional factual information about the company and that its representations and warranties were made for the benefit of the contracting parties.

Important Facts for Investors to Verify

  • Confirm the final number of shares sold, including whether the underwriter exercised any portion of its option.
  • Reconcile the reported approximately $31.75 million of net proceeds with the final offering expenses and share issuance records.
  • Verify the post-reverse-split share count and its effect on historical per-share information and equity plans.
  • Review the underwriter warrant terms, including potential dilution and the $11.00 exercise price.
  • Consult the company’s registration statement and subsequent filings for operating results, use of proceeds, liquidity, risks, and any additional offering-related disclosures.